We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2ceo

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2ceo.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2ceo.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2ceo| PDB=2ceo | SCENE= }}
{{STRUCTURE_2ceo| PDB=2ceo | SCENE= }}
-
'''THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE'''
+
===THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE===
-
==Overview==
+
<!--
-
The hormones that most directly control tissue activities in health and disease are delivered by two noninhibitory members of the serpin family of protease inhibitors, thyroxine-binding globulin (TBG) and corticosteroid-binding globulin. The structure of TBG bound to tetra-iodo thyroxine, solved here at 2.8 A, shows how the thyroxine is carried in a surface pocket on the molecule. This unexpected binding site is confirmed by mutations associated with a loss of hormone binding in both TBG and also homologously in corticosteroid-binding globulin. TBG strikingly differs from other serpins in having the upper half of its main beta-sheet fully opened, so its reactive center peptide loop can readily move in and out of the sheet to give an equilibrated binding and release of thyroxine. The entry of the loop triggers a conformational change, with a linked contraction of the binding pocket and release of the bound thyroxine. The ready reversibility of this change is due to the unique presence in the reactive loop of TBG of a proline that impedes the full and irreversible entry of the loop that occurs in other serpins. Thus, TBG has adapted the serpin inhibitory mechanism to give a reversible flip-flop transition, from a high-affinity to a low-affinity form. The complexity and ready triggering of this conformational mechanism strongly indicates that TBG has evolved to allow a modulated and targeted delivery of thyroxine to the tissues.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16938877}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16938877 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16938877}}
==About this Structure==
==About this Structure==
Line 34: Line 38:
[[Category: Thyroxine-binding globulin]]
[[Category: Thyroxine-binding globulin]]
[[Category: Transport]]
[[Category: Transport]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 21:57:14 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:22:01 2008''

Revision as of 21:22, 27 July 2008

Image:2ceo.png

Template:STRUCTURE 2ceo

THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE

Template:ABSTRACT PUBMED 16938877

About this Structure

2CEO is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural mechanism for the carriage and release of thyroxine in the blood., Zhou A, Wei Z, Read RJ, Carrell RW, Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13321-6. Epub 2006 Aug 28. PMID:16938877

Page seeded by OCA on Mon Jul 28 00:22:01 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2ceo"
Personal tools